Drug firm Strides Arcolab has received approval from the UShealth regulator to market a generic carboplatin injection for the treatment ofovarian cancer. Onco Therapies, a wholly-owned subsidiary of the company, hasreceived United States Food and Drug Administration (USFDA) approval forCarboplatin injections. The approval by the USFDAis for carboplatin injections in strengths of 10 mg/mL, packaged in 50 mg/5 mL,150 mg/15 mL, 450 mg/45 mL and 600 mg/60 mL multi-dose vials. Carboplatinis part of the oncology portfolio licensed to Pfizer in January, 2010, for theUS market and is expected to be launched shortly. Accordingto IMS data of June 11, the US market for generic carboplatin is worth nearly$35 million.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: